Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to investigate whether ATL-104 is safe and well tolerated, and
whether it shows evidence of efficacy in mucositis in patients undergoing PBSCT